9BXG | pdb_00009bxg

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 9BXG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9BXG_NAG_A_503	87%	74%	0.071	0.944	0.34	0.66	-	-	0	0	100%	1
9BXG_NAG_A_505	59%	79%	0.093	0.875	0.32	0.54	-	-	0	0	100%	1
9BXG_NAG_A_507	51%	73%	0.105	0.859	0.47	0.57	-	-	0	0	100%	1
9BXG_NAG_A_501	40%	71%	0.12	0.829	0.43	0.67	-	-	0	0	100%	1
9BXG_NAG_A_504	31%	80%	0.115	0.782	0.42	0.43	-	-	0	0	100%	1
9BXG_NAG_A_508	30%	76%	0.121	0.78	0.48	0.48	-	-	0	0	100%	1
9BXG_NAG_A_509	23%	79%	0.124	0.742	0.35	0.52	-	-	0	0	100%	1
9BXG_NAG_A_506	20%	82%	0.136	0.735	0.36	0.43	-	-	0	0	100%	1
9BXG_NAG_A_502	7%	49%	0.177	0.62	1.14	0.84	2	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
7SX7_NAG_G_502	100%	62%	0.032	0.985	0.67	0.78	-	-	0	0	100%	1
7SX6_NAG_G_504	100%	85%	0.035	0.987	0.21	0.52	-	-	0	0	100%	1
4YFL_NAG_E_507	98%	70%	0.061	0.985	0.48	0.66	-	-	0	0	100%	1
3SE8_NAG_G_734	94%	68%	0.063	0.961	0.56	0.68	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1
7DDF_NAG_B_401	100%	87%	0.02	0.992	0.21	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.